Ads
related to: multiple myeloma- Primary and Subgroup Data
Primary- and Subgroup-
Specific Data
- Phase 3 Trial
Explore the Phase 3 Trial Design,
Results, and Patient Population
- Contact a Representative
For Questions and Information
About This Treatment
- Patient Profile
Potential Treatment Candidates
HCPs, See Who May Be Appropriate
- Primary and Subgroup Data
Search results
Congress evaluate how to lower prescription prices by increasing competition
WSOC-TV Charlotte· 26 minutes agoRoughly 30 percent of Americans say they’re struggling to pay for prescription drugs. “My doctors have me on a four drug combination with a list price of more than one million dollars a year ...
Recent FDA Committee Vote Could Speed Multiple Mye | Newswise
Newswise· 1 day agoA U.S. Food and Drug Administration committee voted unanimously in April to approve a new clinical...
AI Tool Shows Promise in Cancer Therapy Matching, but More Training Data Needed
GenomeWeb News· 15 hours agoA machine learning-based approach could enable the use of computationally intensive single-cell transcriptomic analysis to predict cancer patients' responses to treatment, if researchers can ...
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 17 hours agoLeading AstraZeneca’s efforts is a dual-acting therapy that hits a protein active on multiple ...
HaemaLogiX welcomes former Australian Federal Minister for Health Professor the Hon Greg Hunt to the...
WPRI Providence· 2 days agoHaemaLogiX Ltd, a clinical stage biotech developing novel immunotherapies for patients with blood cancers and B-cell diseases, is pleased to announce the appointment of Professor the Hon Greg ...
Doubt Cast on MGUS-Autoimmune Disease Link
MedPage Today· 2 days agoContrary to earlier studies, the not-entirely-rare condition known as monoclonal gammopathy of undetermined significance (MGUS) did not appear to raise...
p52-ZER6/IGF1R axis maintains cancer stem cell population to promote cancer progression by enhancing...
Nature· 1 day agoCancer stem cells (CSCs), which are distinct subpopulations of tumor cells, have a substantially higher tumor-initiating capacity and are closely related to poor clinical outcomes. Damage to ...
A world without cancer: We can get there from here
Miami Herald via Yahoo News· 3 days agoWhile cancer deaths overall are in decline, more people are getting certain cancers, and people of color, in particular, suffer a disproportionate...
Earnings call: Autolus Therapeutics Reports Progress and Financials for Q1 2024
Investing.com· 4 days agoIn a recent earnings call, Autolus Therapeutics (NASDAQ: AUTL ), a biopharmaceutical company...
1 million veterans have received health benefits for toxic exposure through PACT Act
Stars and Stripes· 1 day agoThe delivery of benefits to veterans exposed to burn pits and other toxins from military service...